Rajendra Prasad

Rajendra Prasad

Auto-generated profile, based on publicly available information

Rajendra Prasad

School of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2025 in Small
Verified
Journal Article
Open access
Nimeet DesaiNimeet Desai
Nimeet Desai
DRDhwani Rana
Dhwani Rana
MPMitali Patel
Mitali Patel
NBNeha Bajwa
Neha Bajwa
RPRajendra Prasad
Rajendra Prasad
Lalitkumar VoraLalitkumar Vora
Lalitkumar Vora
Nanoparticle‐based therapeutics, emerging from advances in nanotechnology, outperform traditional drug therapies by virtue of their distinct biological properties that enhance therapeutic efficacy, reduce toxicity, and enable precise targeting. Since the 1980s, the number of nanoparticle‐based pharmaceutical products has expanded considerably, capturing a significant portion of the pharmaceutical market. These systems function as therapeutic agents or as vehicles for delivering active pharmaceutical or diagnostic compounds to targeted areas. However, despite their transformative potential, the development of comprehensive and harmonized regulatory frameworks for nanomedicines remains a critical challenge. This review provides a current overview of market‐approved nanoparticle therapeutics, analyzing global regulatory strategies, including pre‐clinical testing, safety assessments, manufacturing processes, and quality control standards. By discussing the existing shortcomings, this review highlights the importance of adaptive regulatory pathways in a global context. It aims to support researchers and stakeholders in navigating the regulatory landscape, facilitating the successful commercialization and clinical translation of nanoparticle‐based therapeutics.

19 June 2025 in Nanoscale
Verified
Journal Article
Closed access
PDF file
ASAnkur Singh
Ankur Singh
Supratim MahapatraSupratim Mahapatra
Supratim Mahapatra
RPRajendra Prasad
Rajendra Prasad
SSSumit Kumar Singh
Sumit Kumar Singh
Pranjal ChandraPranjal Chandra
Pranjal Chandra
MXene QDs have garnered the attention of established as well as budding researchers as a new class of nanomaterial due to their exceptional properties and wide applicability. Advancements in nanotechnology and materials science have led the discovery of these, and explorations of their exceptional physicochemical characteristics have positioned them as a cutting-edge nanomaterial with immense potential for future innovation. This review explores the different aspects of MXene QDs, including fundamentals, functionalization, and the doping of precursors. The unique properties, including structural, electronic, optical properties, and biocompatibility, making these promising candidates for use in optoelectronic devices have been thoroughly discussed. The different methods used to formulate MXene QDs into functional versions, including ball milling, pyrolysis, molten salt, hydrothermal, and solvothermal synthesis, and ultrasonication have been elaborated on with suitable examples. This article also includes precise yet insightful discussion on the MXene-QD-based sensing of different molecular categories, viz. small molecules, macromolecules, and environmental pollutants. Additionally, this paper provides insightful discussion on sensor fabrication strategies, limits of detection (LODs), linear detection ranges (LDRs), synthetic routes, and real sample detection, along with the detection techniques involved in sensor development in various studies. This article brings fundamental insights ranging from the synthesis of MXene QDs to their deployment to real-time applications in order to understand the overall research scope along with translational bottlenecks from the perspective of future development.

14 July 2023 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
NKNagavendra Kommineni
Nagavendra Kommineni
RCRuchita Chaudhari
Ruchita Chaudhari
JCJoao Conde
Joao Conde
STSedef Tamburaci
Sedef Tamburaci
BCBerivan Cecen
Berivan Cecen
RPRajendra Prasad
Rajendra Prasad

10 July 2019 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
RPRajendra Prasad
Rajendra Prasad
AYAmit Singh Yadav
Amit Singh Yadav
MGMahadeo Gorain
Mahadeo Gorain
DCDeepak Chauhan
Deepak Chauhan
GKGopal C. Kundu
Gopal C. Kundu
KSKaliaperumal Selvaraj
Kaliaperumal Selvaraj

21 September 2018 in Nanoscale
Verified
Journal Article
Closed access
PDF file
RPRajendra Prasad
Rajendra Prasad
DCDeepak Chauhan
Deepak Chauhan
AYAmit Singh Yadav
Amit Singh Yadav
JDJanhavi Devrukhkar
Janhavi Devrukhkar
BSBarkha Singh
Barkha Singh
RSRohit Srivastava
Rohit Srivastava
A successful design of a novel red fluorescent carbon dots liposomal nanopitchers for deep tissue visualization and on demand phototriggered combined cancer therapy. The laser irradiation produces heat and reactive oxygen species that cause cancer cell death and tumor growth inhibition.

16 March 2026 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
DCDeepak S. Chauhan
Deepak S. Chauhan
RPRajendra Prasad
Rajendra Prasad
MDMukesh Dhanka
Mukesh Dhanka
NKNavneet Kaur
Navneet Kaur
HVHitasha Vithalani
Hitasha Vithalani
CUChannakeshava S. Umeshappa
Channakeshava S. Umeshappa
Nanoparticle-based phototherapy represents a paradigm shift in precision medicine, harnessing light-activated mechanisms to modulate cellular pathways across a spectrum of diseases. By integrating nanoparticles, phototherapeutic modalities achieve enhanced light absorption and improved targeting and amplification effects, such as reactive oxygen species generation in photodynamic therapy and localized heating in photothermal therapy. Gold nanoparticles and hybrid constructs have attracted considerable attention in both photothermal and photodynamic therapies, while delivery platforms, such as liposomes and dendrimers, fine-tune biodistribution and release kinetics. At the molecular level, phototherapy induces oxidative stress, triggers apoptotic and autophagic cascades and modulates immune responses by altering cytokine profiles and T-cell activity processes, which are critical not only in cancer therapy but also in managing various chronic conditions, including cardiovascular, neurodegenerative, metabolic and autoimmune disorders. In this review, we chart the evolution of nanoparticle-based phototherapy systems by examining their core components, classification schemes and delivery platforms that drive treatment specificity. We then dissect the underlying signaling pathways, highlighting how light-triggered interventions intersect with key molecular networks in chronic disease contexts. Additionally, we critically evaluate FDA-approved agents and insights from recent clinical trials, outlining the major challenges to clinical translation, including nanoparticle optimization, efficient light delivery and regulatory hurdles. By integrating molecular insights with clinical advancements, nanoparticle-based phototherapy has emerged as a transformative, noninvasive strategy poised to revolutionize therapeutic approaches for a wide range of diseases.